5 Other Times Relypsa Gained 10% In A Day This Year

Relypsa Inc RLYP shareholders are enjoying yet another double-digit gain in Friday’s session on news that the FDA has rejected AstraZeneca plc (ADR) AZN’s recently-acquired hyperkalemia drug ZS-9. Today isn't the first time this year that Relypsa shareholders have been treated to double-digit one-day gains.

In fact, it’s happened five other times.

Related Link: Overhang For Relypsa Remains, Morgan Stanley Says

• 1. January 20: At one point, Relypsa was up as much as 16.3 percent following the release of an Oppenheimer note saying that the Relypsa sell-off to start the year was overdone.
• 2. January 26: Relypsa surged more than 15.1 percent following the release of positive Phase I results on key drug candidate Veltassa.
• 3. February 11: Relypsa was up as much as 10.6 percent after Spherix Global Insights said that Veltassa was “off to a strong start.”
• 4. April 7: The biggest move of the year was a massive 67.6 percent one-day move following reports that the company was in talks to review potential buyout offers.
• 5. April 21: The stock was briefly up as much as 22.2 percent on renewed rumors that AstraZeneca or another company would make a buyout bid for Relypsa.

Incredibly, despite all the huge one-day gains, Relypsa’s stock remains down 32.8 percent year-to-date.

Disclosure: the author holds no position in the stocks mentioned.